Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Nanobody Based Dual Specific CARs.

De Munter S, Ingels J, Goetgeluk G, Bonte S, Pille M, Weening K, Kerre T, Abken H, Vandekerckhove B.

Int J Mol Sci. 2018 Jan 30;19(2). pii: E403. doi: 10.3390/ijms19020403.

2.

A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivo.

Desombere I, Mesalam AA, Urbanowicz RA, Van Houtte F, Verhoye L, Keck ZY, Farhoudi A, Vercauteren K, Weening KE, Baumert TF, Patel AH, Foung SKH, Ball J, Leroux-Roels G, Meuleman P.

Antiviral Res. 2017 Dec;148:53-64. doi: 10.1016/j.antiviral.2017.10.015. Epub 2017 Oct 23.

3.

The checkpoint for agonist selection precedes conventional selection in human thymus.

Verstichel G, Vermijlen D, Martens L, Goetgeluk G, Brouwer M, Thiault N, Van Caeneghem Y, De Munter S, Weening K, Bonte S, Leclercq G, Taghon T, Kerre T, Saeys Y, Van Dorpe J, Cheroutre H, Vandekerckhove B.

Sci Immunol. 2017 Feb 24;2(8). pii: eaah4232. doi: 10.1126/sciimmunol.aah4232.

4.

Antigen receptor-redirected T cells derived from hematopoietic precursor cells lack expression of the endogenous TCR/CD3 receptor and exhibit specific antitumor capacities.

Van Caeneghem Y, De Munter S, Tieppo P, Goetgeluk G, Weening K, Verstichel G, Bonte S, Taghon T, Leclercq G, Kerre T, Debets R, Vermijlen D, Abken H, Vandekerckhove B.

Oncoimmunology. 2017 Jan 19;6(3):e1283460. doi: 10.1080/2162402X.2017.1283460. eCollection 2017.

5.

HIV-1 Vpr N-terminal tagging affects alternative splicing of the viral genome.

Baeyens A, Naessens E, Van Nuffel A, Weening KE, Reilly AM, Claeys E, Trypsteen W, Vandekerckhove L, Eyckerman S, Gevaert K, Verhasselt B.

Sci Rep. 2016 Oct 10;6:34573. doi: 10.1038/srep34573.

6.

Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infection.

Foquet L, Hermsen CC, van Gemert GJ, Van Braeckel E, Weening KE, Sauerwein R, Meuleman P, Leroux-Roels G.

J Clin Invest. 2014 Jan;124(1):140-4.

7.

Evolution of self-organisation in Dictyostelia by adaptation of a non-selective phosphodiesterase and a matrix component for regulated cAMP degradation.

Kawabe Y, Weening KE, Marquay-Markiewicz J, Schaap P.

Development. 2012 Apr;139(7):1336-45. doi: 10.1242/dev.077099. Epub 2012 Feb 22.

8.

Genetic control of lithium sensitivity and regulation of inositol biosynthetic genes.

King J, Keim M, Teo R, Weening KE, Kapur M, McQuillan K, Ryves J, Rogers B, Dalton E, Williams RS, Harwood AJ.

PLoS One. 2010 Jun 17;5(6):e11151. doi: 10.1371/journal.pone.0011151.

9.
10.

Pharmacological profiling of the Dictyostelium adenylate cyclases ACA, ACB and ACG.

Alvarez-Curto E, Weening KE, Schaap P.

Biochem J. 2007 Jan 1;401(1):309-16.

11.

cAMP signaling in Dictyostelium. Complexity of cAMP synthesis, degradation and detection.

Saran S, Meima ME, Alvarez-Curto E, Weening KE, Rozen DE, Schaap P.

J Muscle Res Cell Motil. 2002;23(7-8):793-802. Review.

PMID:
12952077
12.

Contrasting activities of the aggregative and late PDSA promoters in Dictyostelium development.

Weening KE, Wijk IV, Thompson CR, Kessin RH, Podgorski GJ, Schaap P.

Dev Biol. 2003 Mar 15;255(2):373-82.

13.

Characterization of a cAMP-stimulated cAMP phosphodiesterase in Dictyostelium discoideum.

Meima ME, Weening KE, Schaap P.

J Biol Chem. 2003 Apr 18;278(16):14356-62. Epub 2003 Feb 6.

Supplemental Content

Loading ...
Support Center